367 related articles for article (PubMed ID: 18684282)
61. Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges.
Baumert J; Schmitt C; Ladwig KH
Psychosom Med; 2006; 68(4):591-7. PubMed ID: 16868269
[TBL] [Abstract][Full Text] [Related]
62. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
[TBL] [Abstract][Full Text] [Related]
63. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator.
Cho EN; von Känel R; Marten-Mittag B; Ronel J; Kolb C; Baumert J; Ladwig KH
Heart; 2012 May; 98(10):806-12. PubMed ID: 22543838
[TBL] [Abstract][Full Text] [Related]
64. Avoidance behaviors in patients with implantable cardioverter defibrillators.
Lemon J; Edelman S; Kirkness A
Heart Lung; 2004; 33(3):176-82. PubMed ID: 15136777
[TBL] [Abstract][Full Text] [Related]
65. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience.
Birnie DH; Sears SF; Green MS; Lemery R; Gollob MH; Amyotte B
Europace; 2009 Jan; 11(1):26-30. PubMed ID: 19010798
[TBL] [Abstract][Full Text] [Related]
66. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators.
Sears SF; Conti JB
Am J Cardiol; 2006 Aug; 98(4):565-7. PubMed ID: 16893718
[TBL] [Abstract][Full Text] [Related]
67. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
Hoogwegt MT; Kupper N; Theuns DA; Jordaens L; Pedersen SS
Europace; 2012 Jan; 14(1):74-80. PubMed ID: 21920910
[TBL] [Abstract][Full Text] [Related]
68. Phantom shocks in patients with an implantable cardioverter defibrillator.
Juan EA; Pollack M
J Emerg Med; 2010 Jan; 38(1):22-4. PubMed ID: 18394854
[TBL] [Abstract][Full Text] [Related]
69. A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery.
Hallas CN; Burke JL; White DG; Connelly DT
Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):170-7. PubMed ID: 20197542
[TBL] [Abstract][Full Text] [Related]
70. Psychological implications of ICD implantation in a New Zealand population.
Newall EG; Lever NA; Prasad S; Hornabrook C; Larsen PD
Europace; 2007 Jan; 9(1):20-4. PubMed ID: 17224417
[TBL] [Abstract][Full Text] [Related]
71. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
72. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.
Sears SF; Sowell LD; Kuhl EA; Kovacs AH; Serber ER; Handberg E; Kneipp SM; Zineh I; Conti JB
Pacing Clin Electrophysiol; 2007 Jul; 30(7):858-64. PubMed ID: 17584267
[TBL] [Abstract][Full Text] [Related]
73. Psychological impact of surveillance in patients with a defibrillator lead under advisory: a prospective evaluation.
D'Antono B; Goldfarb M; Solomon C; Sturmer M; Becker G; Essebag V; Hadjis T; Gizicki E; Gelais JS; Sas G; Côté MC; Kus T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):221-30. PubMed ID: 23121081
[TBL] [Abstract][Full Text] [Related]
74. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
Hreybe H; Saba S
Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
[TBL] [Abstract][Full Text] [Related]
75. Social support, anxiety, and support group participation in patients with an implantable cardioverter defibrillator.
Myers GM; James GD
Prog Cardiovasc Nurs; 2008; 23(4):160-7. PubMed ID: 19067979
[TBL] [Abstract][Full Text] [Related]
76. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators.
Serber ER; Finch NJ; Leman RB; Sturdivant LJ; Barnes T; Clarke E; Garry J; Gold MR
Pacing Clin Electrophysiol; 2009 Mar; 32(3):383-90. PubMed ID: 19272070
[TBL] [Abstract][Full Text] [Related]
77. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
78. Long-term outcomes of a telephone intervention after an ICD.
Dougherty CM; Thompson EA; Lewis FM
Pacing Clin Electrophysiol; 2005 Nov; 28(11):1157-67. PubMed ID: 16359281
[TBL] [Abstract][Full Text] [Related]
79. Gender differences in psychological distress and quality of life in patients with an ICD 1-year postimplant.
Starrenburg A; Pedersen S; van den Broek K; Kraaier K; Scholten M; Van der Palen J
Pacing Clin Electrophysiol; 2014 Jul; 37(7):843-52. PubMed ID: 24697703
[TBL] [Abstract][Full Text] [Related]
80. Anxiety and depression among the patients with frequent implantable cardioverter-defibrillator discharges.
Maryniak A; Szumowski L; Orczykowski M; Przybylski A; Walczak F
Int J Cardiol; 2009 Feb; 132(2):e80-1. PubMed ID: 18061290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
